Skip to Content

GSI 7985 (Harvoni ledipasvir 90 mg / sofosbuvir 400 mg)

Generic Name: ledipasvir/sofosbuvir

Pill with imprint GSI 7985 is Orange, Four-sided and has been identified as Harvoni ledipasvir 90 mg / sofosbuvir 400 mg. It is supplied by Gilead Sciences, Inc..

Harvoni is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 90 mg / sofosbuvir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7985

Harvoni ledipasvir 90 mg / sofosbuvir 400 mg GSI 7985
Harvoni ledipasvir 90 mg / sofosbuvir 400 mg GSI 7985
Harvoni ledipasvir 90 mg / sofosbuvir 400 mg GSI 7985

Harvoni

Generic Name
ledipasvir/sofosbuvir
Imprint
GSI 7985
Strength
ledipasvir 90 mg / sofosbuvir 400 mg
Color
Orange
Shape
Four-sided
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-1801

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.